Loading clinical trials...
Loading clinical trials...
Correlation between CMR T1-times, liver T1-times, fibroscan and fluid status to identify the correlation and pathogenesis of liver disease in patients with heart disease.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
Medical University Vienna
Vienna, Austria
Start Date
February 1, 2022
Primary Completion Date
May 1, 2022
Completion Date
January 1, 2023
Last Updated
February 14, 2022
150
ESTIMATED participants
CMR
DIAGNOSTIC_TEST
Lead Sponsor
Medical University of Vienna
NCT04429100
NCT06632444
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07122700